¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"infection control study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
retrospective cohort study
ÈÄÇâÄÚȣƮ¿¬±¸
retrospective study
ÈÄÇ⿬±¸
study
1. ¿¬±¸, Á¶»ç 2. °Ë»ç, °Ë»ö
study design
¿¬±¸¼³°è
single blind study
´ÜÀϸͰ˿¬±¸
urodynamic study
¿ä¿ªµ¿Çа˻ç
video-urodynamic study
¿µ»ó¿ä¿ªµ¿Çа˻ç
accuracy control
Á¤È®µµ°ü¸®
awaking drug control law
°¢¼ºÁ¦Á¶Àý¹ý
air pollution control
´ë±â¿À¿°°ü¸®
biologics control laboratory
»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò
birth control
»ê¾ÆÁ¦ÇÑ
bite control
±³ÇÕÁ¶Á¤
communicable disease control
Àü¿°º´°ü¸®
conception control
¼öÅÂÁ¶Àý
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
11
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
neonatal infection
°«³¾Ö°¨¿°, ½Å»ý¾Æ°¨¿°
opportunistic infection
±âȸ°¨¿°
oral infection
ÀԾȰ¨¿°, °æ±¸°¨¿°
primary infection
ÀÏÂ÷°¨¿°
protozoan infection
¿øÃæ°¨¿°
secondary infection
ÀÌÂ÷°¨¿°
systemic infection
Àü½Å°¨¿°
vaginal infection
Áú°¨¿°
wound infection
»ó󰨿°
infection route
°¨¿°°æ·Î
infection source
°¨¿°¿ø, Àü¿°¿ø
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
observational study
°üÂû¿¬±¸
pilot study
¿¹ºñ½ÇÇè
population study
Àα¸Á¶»ç
preclinical study
ÀÓ»óÀü½ÃÇè
pressure flow study
¾Ð·Â¿ä·ù°Ë»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
professional activity study
Àü¹®°¡È°µ¿¿¬±¸
prospective study
°èȹ¿¬±¸, ÀüÇ⿬±¸, ¾Õ¹æÇ⿬±¸
real time study
½Ç½Ã°£°Ë»ç
retrospective study
ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸
study
¿¬±¸, °Ë»ç
single blind study
´ÜÀϸͰ˹ý
survivorship study
»ýÁ¸¿¬±¸
time study
½Ã°£¿¬±¸
tracer study
ÃßÀûÀÚ¿¬±¸
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
quality control
Á¤µµ°ü¸®
quality control
ǰÁú°ü¸®(̰̤˴Ëö).
quality control
ÈÁú °ü¸®, ǰÁú°ü¸®
quality control program
Á¤µµ°ü¸®°èȹ
quality control, QC
ǰÁú°ü¸®, Á¤µµº¸Áõ, Á¤µµ°ü¸®
Borrelia recurrentis infection
Àç±Í¿±Õ °¨¿°.
Coxsackie virus infection
ÄÛ»èŰ¹ÙÀÌ·¯½º°¨¿°.
Denal infection
Ä¡¾Æ°¨¿°
ECHO virus infection
¿¡ÄÚ¹ÙÀÌ·¯½º°¨¿°.
ECHO virus infection
¿¡ÄÚ¹ÙÀÌ·¯½º°¨¿°.
Gag antigen in HIV infection
HIV °¨¿°ÀÇ gag Ç׿ø
HIV infection
HIV °¨¿°
HIV infection diagnosis
HIV °¨¿°Áø´Ü
Hemophilus infection
Çì¸ðÇʷ罺°¨¿°, È£Ç÷±Õ°¨¿°.
Infection
°¨¿°(Êïæø)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
tracer study
ÃßÀûÀÚ¿¬±¸(õÚîæíºæÚϼ).
twin study
½Ö»ý¾Æ¿¬±¸(¡æÚϼ).
twin study
½Ö»ý¾Æ¿¬?¡æÚϼ)
urodynamic study
¿ä¿ªµ¿ÇÐ °Ë»ç
validity of clinical study
video-urodynamic study
ºñµ¥¿À ¿ä¿ªÇа˻ç
water-loading study
¼öºÐ-ºÎÇÏ ½ÃÇè
accuracy control
Á¤È®¼º Á¶Àý
admission by legal control
Á¶Ä¡ÀÔ¿ø.
air pollution control
´ë±â¿À¿°¹æÁö<±ÔÁ¦> (ÊÙËÑ̤<˻̡>).
awaking drug control law
°¢¼ºÁ¦Á¶Àý¹ý.
biologics control
»ý¹°Á¦Á¦°ËÁ¤(ÊÙÌ¡Ì¡Ë§Ëø).
biologics control
»ý¹°Á¦Á¦°ËÁ¤(¡ð²ð¥ËþïÒ).
biologics control laboratory
[º´¸®,¹Ì»ý,±â»ý,¸é¿ª,¹ÙÀÌ,¿¹¹æ]»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò(Ë×ËÑ̡̡˴ËöËàÌ´ËÛ).
biologics control laboratory
º´¸®,¹Ì»ý,±â»ý,¸é¿ª,¹ÙÀÌ,¿¹¹æ»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò(ßæÚªð²ð¥Î·ìµãËúÐá¶).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½